✦ LIBER ✦

PMH41 COST-UTILITY ANALYSIS OF ESCITALOPRAM VERSUS CITALOPRAM IN MAJOR DEPRESSIVE DISORDER IN ISRAEL

✍ Scribed by Leshno, M; Ben-Amnon, Y; Brignone, M; Marteau, F; Hansen, K

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PMH13 COST-EFFECTIVENESS OF ESCITALOPRAM

✍ B Fantino; N Moore 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 66 KB

PMH46 COST-EFFECTIVENESS ANALYSIS OF ESC

✍ W Kulp; M Hemels; W Greiner; J Schulenburg Graf von der 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 64 KB

PMH26 COST-EFFECTIVENESS ANALYSIS OF ESC

✍ ME Hemels; O Karamustafaloglu; E Ozmen; S Dilsad; S Mene 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 68 KB

PMH29 COST-EFFECTIVENESS OF ESCITALOPRAM

✍ ME Hemels; S Kasper; E Walter; T Enron 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 46 KB

PMH39 THE COST-UTILITY OF AGOMELATINE IN

✍ Golicki, D; Pajaąk, K; Dbrowska, A; Niewada, M 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 97 KB

PMH52 ECONOMIC ANALYSIS OF ESCITALOPRAM

✍ J Walczak; G Nogas; M Garbacka; G Obrzut; I Pieniazek 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 76 KB